Desipramine Modulation of α-, γ-Synuclein, and the Norepinephrine Transporter in an Animal Model of Depression

被引:0
作者
Alexis M Jeannotte
John G McCarthy
Eva E Redei
Anita Sidhu
机构
[1] Georgetown University Medical Center,Department of Biochemistry and Molecular and Cell Biology
[2] Georgetown University,Department of Psychiatry and Behavioral Sciences
[3] Interdisciplinary Program in Neuroscience,undefined
[4] Georgetown University Medical Center,undefined
[5] Georgetown University,undefined
[6] Northwestern University,undefined
来源
Neuropsychopharmacology | 2009年 / 34卷
关键词
-synuclein; -synuclein; desipramine; microtubule; Parkinson's disease; depression;
D O I
暂无
中图分类号
学科分类号
摘要
The mechanisms underlying depression remain elusive. We previously determined that α-synuclein (α-Syn) modulates the activity and trafficking of the norepinephrine transporter (NET) in a manner that is dependent on its interactions with microtubules (MTs). Here we sought to determine if α-Syn, or the other synuclein family members, β-synuclein (β-Syn) and γ-synuclein (γ-Syn), modulate NET activity in an animal model of depression, the Wistar–Kyoto (WKY) rat. The NET-selective antidepressant desipramine (DMI) was chronically administered for 14 days to WKY rats and the strain from which it was outbred that does not show depressive-like behavior, the Wistar rat. This drug regimen induced significant behavioral improvements in the WKY, but not the Wistar rat, in the forced swim test. In WKY rats there was an overexpression of γ-Syn which was reduced following DMI treatment. In parallel, DMI caused an increase in both α-Syn and NET in the frontal cortex. Frontal cortex synaptosomes from WKY rats were not sensitive to nocodazole, a compound that promotes MT destabilization. However, in WKYs treated with DMI, nocodazole induced an increase in [3H]-NE uptake. This trend was reversed in Wistars. Underlying these DMI-induced changes were alterations in the protein interactions between the synucleins and NET with the tubulins. These results are the first to implicate α-Syn or γ-Syn in the pathophysiology of depression and suggest that targeting synucleins may provide a new therapeutic option for depression.
引用
收藏
页码:987 / 998
页数:11
相关论文
共 202 条
  • [1] Allain HS(2000)Depression in Parkinson's disease BMJ 320 1287-1288
  • [2] Schuck S(1992)Effects of repeated administration of desipramine or electroconvulsive shock on norepinephrine uptake sites measured by [ Brain Res 582 208-214
  • [3] Mauduit N(2004)H]nisoxetine autoradiography Biol Psychiatry 55 313-316
  • [4] Bauer ME(2005)Regulation of the norepinephrine transporter by chronic administration of antidepressants Cell 123 359-361
  • [5] Tejani-Butt SM(2003)Snaring the function of alpha-synuclein Eur J Neurosci 18 1923-1938
  • [6] Benmansour S(2005)Distribution of alpha- and gamma-synucleins in the adult rat brain and their modification by high-dose cocaine treatment Cell 123 383-396
  • [7] Altamirano AV(1998)Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration Trends Neurosci 21 249-254
  • [8] Jones DJ(1999)The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease J Neurosci Res 58 120-129
  • [9] Sanchez TA(1998)Synucleins in synaptic plasticity and neurodegenerative disorders J Biol Chem 273 9443-9449
  • [10] Gould GG(1995)Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes Psychopharmacology (Berl) 121 66-72